Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...